Jon P. Stonehouse - 14 Dec 2021 Form 4 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
President & CEO, Director
Signature
/s/ Alane P. Barnes, by power of attorney
Issuer symbol
BCRX
Transactions as of
14 Dec 2021
Net transactions value
$0
Form type
4
Filing time
16 Dec 2021, 15:53:41 UTC
Previous filing
07 Jul 2021
Next filing
01 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCRX Common Stock Gift $0 -5,000 -0.63% $0.000000 783,602 01 Sep 2021 Direct F1
transaction BCRX Common Stock Gift $0 -5,000 -0.64% $0.000000 778,602 01 Sep 2021 Direct F2
transaction BCRX Common Stock Gift $0 +5,000 $0.000000 5,000 01 Sep 2021 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust F1
transaction BCRX Common Stock Gift $0 +5,000 $0.000000 5,000 01 Sep 2021 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust F2
transaction BCRX Common Stock Award $0 +123,000 +16% $0.000000 901,602 14 Dec 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCRX Emp. Stock Option (Right to Buy) Award $0 +574,500 $0.000000 574,500 14 Dec 2021 Common Stock 574,500 $11.43 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a gift of shares by the reporting person to the Samuel Stonehouse Irrevocable Trust.
F2 Reflects a gift of shares by the reporting person to the Caroline Stonehouse Irrevocable Trust.
F3 Annual award of Restricted Stock Units which will vest 25% on each of the first, second, third and fourth anniversaries of the date of grant.
F4 Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant.